STPF “POLYSAN” Ltd. is a successful pharmaceutical company with extensive scientific capabilities and its own high-tech manufacturing facility. The company produces 4 original drug products: Cycloferon (has antiviral, immunomodulatory, anti-inflammatory effects), Cytoflavin (intended for treatment of brain dysfunctions and restoration of cerebral circulation), Reamberin (prevents exogenous and endogenous intoxications of various etiologies) and Remaxol (complex treatment of liver diseases), as well as a modern antihistamine drug product Allergostin.  The pharmaceutical plant POLYSAN produces over 30 million packages of pharmaceutical drug products annually. A substancial part of the company’s product portfolio is included in the vital and essential drug products’ list.

The company’s products are marketed in Russia, the CIS countries, Southeast Asia and Mongolia. The company has been implementing local contract manufacturing projects of drug products from Stada, Bayer, Pfizer international concerns.

At the end of 2018, the third stage of the pharmaceutical plant was commissioned designed for expansion of tablets manufacturing output by more than 3 times. In November 2019, the Research and Development center of POLYSAN — a unique platform for innovative domestic drug products development — was officially opened.

The main mission of POLYSAN: to invest all its efforts, all its scientific potential in the development and production of safe and effective pharmaceutical products.

POLYSAN – intellectual protection of health.